Northern Mariana Islands Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.

Press releases published on July 14, 2026

34 minutes ago

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Indeterminate GlobeNewswire

an hour ago

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

an hour ago

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire

an hour ago

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Indeterminate GlobeNewswire

an hour ago

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Indeterminate GlobeNewswire

an hour ago

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

an hour ago

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Indeterminate GlobeNewswire

an hour ago

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire

an hour ago

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire

an hour ago

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Indeterminate GlobeNewswire

2 hours ago

Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry

Indeterminate GlobeNewswire

2 hours ago

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Indeterminate GlobeNewswire

2 hours ago

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Indeterminate GlobeNewswire

2 hours ago

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire

3 hours ago

Texas Hemp Business Council Releases New Public Health Analysis on THC Regulation and Public Health Priorities

Indeterminate GlobeNewswire

3 hours ago

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Indeterminate GlobeNewswire

4 hours ago

Nucleome Therapeutics strengthens global IP portfolio with US patent for core MCC Technology

Indeterminate GlobeNewswire

5 hours ago

ViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its Board

Indeterminate GlobeNewswire

6 hours ago

ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026

Indeterminate GlobeNewswire